Nortriptyline in the treatment of panic disorder and agoraphobia with panic attacks

Journal of Clinical Psychopharmacology

Volumn 8, Issue 3, 1988, Pages 204-207

  Munjack, Dennis J ^a   Usigli, Rodolfo ^a   Zulueta, Anicia ^a   Crocker, Benjamin ^a   Adatia, Navin ^a   Buckwalter, J Galen ^a   Baltazar, Patricia ^a   Kurvink, William ^a   Inglove, Herbert ^a   Kelly, Robert ^a   Leonard, Michele ^a  

^a LAC USC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NORTRIPTYLINE;

ADULT; AGORAPHOBIA; CLINICAL ARTICLE; HUMAN; ORAL DRUG ADMINISTRATION; PANIC; PSYCHOLOGICAL ASPECT;

ADULT; AGORAPHOBIA; ANALYSIS OF VARIANCE; FEAR; FEMALE; HUMAN; MALE; MIDDLE AGE; NORTRIPTYLINE; PANIC; PHOBIC DISORDERS;

EID: 0023888817     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/00004714-198806000-00010     Document Type: Article

References (17)

1. Zitrin CM, Klein DF, Woerner MG. Behavior therapy, supportive therapy and phobias. Arch Gen Psychiatry 1978;35:307-16.
2. Zitrin CM, Klein DF, Woerner MG. Treatment of agoraphobia with group exposure in vivo and imipramine. Arch Gen Psychiatry 1980;37:64-72.
3. Sheehan DV, Ballenger J, Jacobsen G. Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms. Arch Gen Psychiatry 1980;37:51-9.
4. Liebowitz MR. The efficacy of antidepressants in anxiety disorders. In: Grinspoon L, ed. Psychiatric update, the American Psychiatric Association annual review, vol 3.1984;503-19.
5. Sheehan DV. Current views on the treatment of panic and phobic disorders. Drug Ther 1982;12:49-63.
6. Klerman GL, Coleman JH, Purpura RT. The design and conduct of the Upjohn cross national collaborative panic study. Psychopharmacol Bull 1986;22:59-64.
7. Heiser JF, DeFrancisco D. The treatment of pathological panic states with propranolol. Am J Psychiatry 1976;133:1389-94.
8. Munjack DJ, Rebal R, Shaner R, Staples F, Braun R, Leonard M. Imipramine versus propranolol for the treatment of panic: a pilot study. Compr Psychiatry 1985;26:80-9.
9. Noyes R Jr, Anderson DJ, Clancy J, Crowe RR, Slymen DJ, Ghoneim MM, Hinrichs JV. Diazepam and propranolol in panic disorder and agoraphobia. Arch Gen Psychiatry 1984;41:287-92.
10. Hoehn-Saric R, Merchant AF, Keyser ML, Smith VK. Effects of clonidine on anxiety disorder. Arch Gen Psychiatry 1981:39:1278-82.
11. Liebowitz MR, Fyer AJ, McGrath P, Klein DF. Clonidine treatment of panic disorder. Psychopharmacol Bull 1981;17:122-3.
12. Sheehan D, Davidson J, Manschreck T, Van Wych Fleet J. Lack of efficacy of a new antidepressant (bupropion) in the treatment of panic disorder with phobias. J Clin Psychopharmacol 1983:3:28-31.
13. Beck AT, Ward CH, Mendelson M, Mock JE, Erbaugh JK. An inventory for measuring depression. Arch Gen Psychiatry 1961;4: 561-71.
14. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
15. Keppel G. Design and analysis: a researcher’s handbook. Inglewood Cliffs, NJ: Prentice Hall, 1973.
16. Mavissakalian M, Michelson L. Self directed in vivo exposure practice in behavioral and pharmacological treatment of agoraphobia. Behav Ther 1983;14:506-19.
17. Marks IM, Gray J, Cohen SC, Hill R, Mawson D. Ramm L, Sterns RS. Imipramine and brief therapist-aided exposure in agoraphobics having self-exposure homework: a controlled trial. Arch Gen Psychiatry 1983;40:153-62.